Melnick, Ari M.
Weill Cornell Medicine,
United States
2025 Rank: 41606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 801 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41606 | 44966 |
| Total Cites | 3309 | 3761 |
| H-index | 24 | 25 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 30 | 30 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 675 | 729 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2599 | 2823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
12.02%
|
|
Melnick, Ari M.
Weill Cornell Medicine,
United States
2024 Rank: 28719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 598 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28719 | 30492 |
| Total Cites | 3381 | 3797 |
| H-index | 26 | 28 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 24 | 24 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 760 | 821 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2575 | 2804 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.35 |
| Self-Citation Percentage |
10.96%
|
|
Melnick, Ari M.
Weill Cornell Medicine,
United States
2023 Rank: 41017
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 930 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41017 | 39912 |
| Total Cites | 3431 | 3791 |
| H-index | 25 | 27 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 846 | 926 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2588 | 2743 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
9.50%
|
|
Melnick, Ari M.
Weill Cornell Medicine,
United States
2022 Rank: 23245
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 623 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23245 | 24075 |
| Total Cites | 3504 | 3933 |
| H-index | 26 | 27 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 29 | 29 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 825 | 970 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2596 | 2752 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
10.91%
|
|
Melnick, Ari M.
Weill Cornell Medicine,
United States
2021 Rank: 31516
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 798 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31516 | 31154 |
| Total Cites | 4859 | 5530 |
| H-index | 31 | 33 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 41 | 41 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 1122 | 1324 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3648 | 3875 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.43 |
| Self-Citation Percentage |
12.13%
|
|
Melnick, Ari M.
Weill Cornell Medicine,
United States
2020 Rank: 27327
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 639 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27327 | 26596 |
| Total Cites | 3419 | 3850 |
| H-index | 25 | 28 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 47 | 47 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 833 | 975 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2561 | 2736 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
11.19%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.